Table 2 Clinic features of the TG and non-TG groups at the time of biopsy
From: Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation
Clinic features | TG (n = 43) | non-TG(n = 43) | P value |
|---|---|---|---|
Proteinuria (g/24 h) | 2.01 ± 1.60 | 0.89 ± 0.96 | 0.001 |
Patients with proteinuria | 40 (93.0%) | 20 (46.5%) | <0.001 |
 <1 g/24 h | 10 (23.3%) | 9 (20.9%) | 0.565 |
 1-3.5 g/24 h | 22 (51.2%) | 10 (23.2%) | 0.007 |
 >3.5 g/24 h | 8 (18.6%) | 1 (2.3%) | 0.014 |
Hematuria | 13 (30.2%) | 5 (11.6%) | 0.034 |
Hemoglobin (g/dl) | 9.48 ± 2.18 | 10.66 ± 2.01 | 0.011 |
Patients with anemia | 37 (86.0%) | 28 (65.1%) | 0.022 |
 Mild (9-12 g/dl) | 17 (39.5%) | 18 (41.9%) | 0.500 |
 Moderate (6-9 g/dl) | 18 (41.9%) | 10 (23.3%) | 0.050 |
 Severe (<6 g/dl) | 2 (4.7%) | 0 | 0.247 |
Albumin (g/L) | 33.79 ± 4.89 | 39.50 ± 4.48 | 0.330 |
Hypoalbuminemia | 26 (60.5%) | 5 (11.6%) | <0.001 |
Creatinine (mg/dl)* | 2.12 ± 1.26 | 2.00 ± 1.02 | 0.600 |
Patients with the history of rejection | 15 (34.9%) | 14 (32.6%) | 0.943 |
HCV infection | 15 (34.9%) | 3 (7.0%) | 0.003 |
HLA-I antibodies present | 9/30(30%) | 1/23 (4.3%) | 0.018 |
HLA-II antibodies present | 17/30 (56.7%) | 4/23 (17.4%) | 0.004 |